Press Release

Qualcomm Provides £330,000 (US$500,000) to Establish Scholarships in Biomedical Engineering at University of Oxford

Funding Provides Means for Most Highly Rated MSc Graduates to Continue into Doctoral Studies

Nov 19, 2008LONDON

Qualcomm products mentioned within this press release are offered by Qualcomm Technologies, Inc. and/or its subsidiaries.

Qualcomm Incorporated (Nasdaq: QCOM), a leading developer of advanced wireless technologies and data solutions, today announced funding of £330,000 (US$500,000) to establish four scholarships aimed at supporting top Master of Science (MSc) graduates of the University of Oxford's Biomedical Engineering (BME) programme as they continue into their doctoral studies. The donation, which establishes the Qualcomm Scholarships in Biomedical Engineering at the Oxford Institute of Biomedical Engineering, reflects Qualcomm's commitment to fostering exceptional talent and extending innovation into new markets.

“Biomedical engineering is an emerging discipline promising exciting advancements in clinical and medical sciences that will ultimately enhance health care for us all,” said John Caterer, managing director of Qualcomm UK. “By establishing these scholarships in collaboration with the University of Oxford, Qualcomm is contributing very directly to the betterment of society.”

“Qualcomm's generous gift will not only enable four of the most highly rated graduates of our programme to continue their studies, but it also has the potential to make a major contribution to unmet clinical needs worldwide,” said Dr. J. Frederick Cornhill, founding director of the Oxford Institute of Biomedical Engineering.

The four scholarships will provide support for the students' entire doctoral programmes (usually 42 months) and will be awarded to the two most highly ranked students in the BME MSc programme by an internal academic committee at the University of Oxford. The first two scholarships will be awarded in June 2009, enabling students to begin their DPhil studies in October 2009. The second two scholarships will be awarded in June 2010 with studies beginning in October 2010.

“Oxford University is enormously grateful for the donation from Qualcomm,” said Dr. John Hood, vice-chancellor of Oxford University. “The University of Oxford has a long history of excellence in biomedical engineering and education and these new scholarships will help us in the core activity of training the next generation of biomedical engineers.”

Qualcomm Incorporated (Nasdaq: QCOM) is a leader in developing and delivering innovative digital wireless communications products and services based on CDMA and other advanced technologies. Headquartered in San Diego, Calif., Qualcomm is included in the S&P 100 Index, the S&P 500 Index and is a 2008 FORTUNE 500® company. For more information, please visit www.qualcomm.com.

###

Qualcomm is a registered trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

©2020 Qualcomm Technologies, Inc. and/or its affiliated companies.

References to "Qualcomm" may mean Qualcomm Incorporated, or subsidiaries or business units within the Qualcomm corporate structure, as applicable.

Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses. Qualcomm products referenced on this page are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Materials that are as of a specific date, including but not limited to press releases, presentations, blog posts and webcasts, may have been superseded by subsequent events or disclosures.

Nothing in these materials is an offer to sell any of the components or devices referenced herein.